HMBS and neoplasm: In over 80% of all tumors, the genes for hydroxymethylbilane synthase (HMBS), the third enzyme of the heme biosynthetic pathway, and the heme exporter FLVCR1 were among the most commonly up-regulated across diverse tumor types (Figs S5A and B and S6) (Table S5).